If you have been exposed to TB, you may be infected but have no symptoms and not be contagious. Between 20 to 30% of people exposed to a person with active TB become infected. For that reason, doctors usually distinguish between infection (or a positive TB test) and an active infection. After you are infected, your immune system will attack the bacteria. Your body may kill all the bacteria, the bacteria may remain in your body but not cause an active infection, or you may develop the disease. TB can affect other areas of your body outside of the lungs, but lung infection is most common. Typically, TB bacteria that grow in the lungs may cause:
Mycobacterium tuberculosis causes most cases of TB. The disease is spread from one person to another through airborne bacteria. However, it is not easy to catch TB. You need consistent exposure to the contagious person for a long time. For that reason, you are more likely to catch TB from a relative than a stranger. Typically, a person with TB in the lungs or the throat, coughs or sneezes, and people nearby then breathe in the bacteria. When a person breathes in TB bacteria, the bacteria can settle into the lungs and begin to grow.
Because TB is only spread through inhalation of infected respiratory particles in the air (see What Causes It? section), you are not likely to contract the infection through other means, such as handshakes or sharing dishes and utensils. People with TB are most likely to spread it to people with whom they spend the most time, such as family members, friends, classmates, and coworkers. Risk factors for developing TB include:
If your doctor suspects a TB infection, you will need a skin test. A positive reaction to the test means you are likely infected with TB, although false positive and false negative results are possible. To confirm the diagnosis and determine if the infection is active, you may need to have samples taken of your sputum (mucus and other material coughed up from the lungs) or stomach fluid to check for TB bacteria, as well as a chest x-ray.
TB is difficult to treat (see "Drug Therapies") so prevention is important. Prevention of TB begins with rapid diagnosis and treatment to avoid spread to noninfected persons. In countries where TB is common, a vaccine called BCG may be administered. However, the vaccine causes a false positive on the skin test and is not very effective in adults, so it is rarely given in the U.S.
If you are at risk, you should be tested for TB every 6 months. If you test positive but have no signs of active infection, you may be given the medication isoniazid to prevent an active infection.
The most important way to keep TB from spreading is for infected people to take their medications exactly as prescribed. If you do not take all of your medications, you run the risk of developing multidrug resistant TB, which you can then spread to others. Drug resistant TB is a major health problem in the U.S. and around the world. If you have TB, keeping all of your clinic appointments is essential so that your doctor can check for side effects from the drugs and evaluate the effectiveness of the treatment. If you are sick enough with TB to go to a hospital, you may be put in a special room with air vents that keep the TB bacteria from spreading. You will most likely be prevented from leaving your room while you are contagious (about 2 weeks after treatment begins). People who come into the room will wear special face masks to protect themselves from TB bacteria and to prevent the spread of TB bacteria to others.
If your doctor suspects TB, treatment may begin before all lab tests return. This may include more than one anti-TB drug. Emergency treatment may be necessary if, for example, you are coughing up blood.
TB bacteria die very slowly. It takes 6 months to a year for the medicine to destroy all of the TB bacteria, longer for multidrug resistant TB. If you have TB, you will need to take several different drugs. You will be tested first for drug resistance to determine the most effective combination of drugs to prevent the bacteria from becoming resistant to the drugs. The most common drugs used to fight TB are:
TB should never be treated with alternative therapies alone. To cure the disease, and avoid spreading it to other people, you must be treated with prescription medications. Some complementary and alternative therapies (CAM) treatments may be useful as supportive therapies.
Even if complementary therapies are used, conventional prescription drugs must be taken exactly as directed. CAM therapies do not allow people to get by with less medicine or to skip doses. Skipping doses is a major cause of the development of drug resistant strains and greater spread of the disease.
Following these nutritional tips may help reduce risks and symptoms:
You may address nutritional deficiencies with the following supplements:
Animal studies suggest that TB may be more severe in persons with diets rich in omega-3 essential fatty acids. These studies are not comprehensive, and it is not clear whether there is a similar effect in humans. Until researchers know more, however, it may be wise to avoid omega-3 supplements (such as fish oil) if you have or are at risk for TB.
Herbs are generally available as standardized, dried extracts (pills, capsules, or tablets), teas, or tinctures/liquid extracts (alcohol extraction, unless otherwise noted). Mix liquid extracts with favorite beverage. Dose for teas is 1 to 2 heaping tsp/cup water steeped for 10 to 15 minutes (roots need longer). Although herbs should never be used alone to treat TB, some herbs may be helpful when used in conjunction with conventional medical treatment.
Few studies have examined the effectiveness of specific homeopathic remedies. Professional homeopaths, however, may recommend one or more of the following treatments for tuberculosis based on their knowledge and clinical experience. Before prescribing a remedy, homeopaths take into account a person's constitutional type, includes your physical, emotional, and intellectual makeup. An experienced homeopath assesses all of these factors when determining the most appropriate remedy for a particular individual.
Acupuncture can help strengthen your immune system response, as well as support your lung function.
A full course of medication can cure TB in people who do not have a multidrug resistant strain. It can be fatal in the elderly. It may also be deadly among people whose disease has spread to locations other than the lungs including miliary TB (which spreads through the bloodstream affecting many organ systems), in those with multidrug resistant strains of TB, or in those with HIV.Possible complications of TB include:Development of a multidrug resistant strainTB beyond the lungs, frequently associated with HIVTB-related meningitis, in childrenPneumothorax (collapse of a lung due to a buildup of gas between the membranes that surround the lungs)Massive coughing up of blood
U.S. public health policy requires health care providers to report cases of TB and to treat or quarantine all people infected. Most people may remain at home, but all should be kept from any new contacts for at least 2 weeks after treatment begins. The elderly and those who are acutely ill or have multidrug resistant TB should be hospitalized for the first few weeks of treatment.
It is essential to take all TB medication exactly as prescribed in order to cure TB and prevent drug resistance. Doctors will collect and test sputum samples monthly. If tests are still positive after 3 months of treatment, the infection is considered multidrug resistant and a change in medications is in order.
Since effective treatment of TB depends on taking multiple antibiotic drugs for an extended period of time, it is essential that you consult with your health care provider before using complementary or alternative therapies, including taking herbs and vitamin supplements.
Abubakar I et al. Controversies and unresolved issues in tuberculosis prevention and control: a low-burden-country perspective. J Infect Dis. 2012;205 Suppl 2:S293-300.
Bafica A, Scanga CA, Serhan C, Machado F, et al. Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production. J Clin Invest. 2005 June 1;115(6):1601-1606.
Baker MA, Lin HH, Chang HY, Murray MB. The risk of tuberculosis disease among persons with diabetes mellitis: a prospective cohort study. Clin Infect Dis. 2012;54(6):818-25.
Bastian I, Colebunders R. Treatment and prevention of multidrug-resistant tuberculosis. Drugs. 1999;58(4):633-661.
Ben m'rad M, Gherissi D, Mouthon L, Salmon-Ceron D. Tuberculosis risk among patients with systemic diseases. Presse Med. 2009;38(2):274-90.
Bope: Conn's Current Therapy 2012. 1st ed. Philadelphia, PA: Elsevier Saunders; 2011.
Bornman L, et al. Vitamin D receptor polymorphisms and susceptibility to tuberculosis in West Africa: a case-control and family study J Infect Dis. 2004 Nov 1;190(9):1631-41.
Franke MF, Appleton SC, Mitnick CD, et al. Aggressive regimens for multidrug-resistant tuberculosis reduce recurrence. Clin Infect Dis. 2013;56(6):770-6.
Getahun H, sculier D, Sismanidis C, Grzemska M, Raviglione M. Prevention, diagnosis, and treatment of tuberculosis in children and mothers: evidence for action for maternal, neonatal, and child health services. J Infect Dis. 2012;205 Suppl 2:S216-27.
Goldman: Goldman's Cecil Medicine. 24th ed. Philadelphia, PA: Elsevier Saunders; 2011.
Huang CC, Tchetgen ET, Becerra MC, et al. The effect of HIV-related immunosuppression on the risk of tuberculosis transmission to household contacts. Clin Infect Dis. 2014;58(6):765-74.
Jones-Lopez EC, Namugga O, Mumbowa F, et al. Cough aerosols of Mycobacterium tuberculosis predict new infection: a household contact study. Am J Respir Crit Care Med. 2013; 187(9):1007-15.
Karp CL, Andrea M. Cooper AM. An oily, sustained counter-regulatory response to TB. J Clin Invest. 2005 June 1;115(6): 1473-1476.
Kliiman K, Altraja A. Predictors of extensively drug-resistant pulmonary tuberculosis. Ann Intern Med. 2009;150(11):766-75.
Liu PT, Stenger S, Li H, Wenzel L, Tan BH, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006 March 24;311:1770-1773.
Mason: Murray and Nadel's Textbook of Respiratory Medicine. 5th ed. Philadelphia, PA: Elsevier Saunders; 2010.
Newton SM, Lau C, Wright CW. A review of antimycobacterial natural products. Phytother Res. 2000;14(5):303-322.
Niu HR, Lai ZH, Yuan L. Observation on effect of supplementary treatment by Astragalus injection in treating senile pulmonary tuberculosis patients. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2001 May;21(5):349-50.
Schlossberg D. Acute Tuberculosis. Infectious Disease Clinics of North America. 2010;24(1).
Uhlin M, Andersson J, Zumla A, Maeurer M. Adjunct immunotherapies for tuberculosis. J Infect Dis. 2012;205 Suppl 2:S325-34.
Wilkinson D. Drugs for preventing tuberculosis in HIV infected persons. Cochrane Database Syst Rev. 2000;No. 2:CD000171.
Wilkinson RJ, Llewelyn M, Toossi Z, et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet. 2000;355(9204):618-621.
Wingfield T, Schumacher SG, Sandhu G, et al. The seasonality of tuberculosis, sunlight, vitamin D, and household crowding. J Infect Dis. 2014;210(5):774-83.
Wright A, et al. Epidemiology of antituberculosis drug resistance 2002 - 07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet. 2009;373(9678):1861-73.
Zumla A et al. Drug-resistant tuberculosis -- current dilemmas, unanswered questions, challenges, and priority needs. J Infect Dis. 2012;205 Suppl 2:S228-40.